Adolfo Aleman, Jr.^1*, Rongbao Zhao, PhD^2,3*, Leah Grossman^4*, Rahul Sanawar, PhD^2*, Srinivas Aluri, PhD², Mani Mohindru, PhD^5*, Rudra Prasad Dutta^6*, Sidorela Reci, BS^7*, Junia Vieira, MD, PhD^1*, David Melnekoff, PhD^1*, Alessandro Lagana, PhD⁸, Shriya Desai, BS^9*, Sundar Jagannath^8,10, Amit Verma, MD² and Samir Parekh, MD¹

¹Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²Blood Cancer Institute, Department of Oncology, Albert Einstein College of Medicine, Bronx, NY
³Montefiore Einstein Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
⁴Icahn School of Medicine at Mt. Sinai, New York, NY
⁵Roshon Therapeutics, Scarsdale, NY
⁶Hematology and Molecular Oncology, Icahn School of Medicine at Mt. Sinai, New York, NY
⁷Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
⁸Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
⁹Hematology and Medical Oncology, Icahn School of Medicine at Mt. Sinai, New York, NY
¹⁰Mount Sinai Medical Center, New York, NY

Yoshinobu Konishi, MD, PhD^1,2,3, David M. Cordas Dos Santos, MD^1,3,4*, Jacopo U. Verga^3,4,5,6*, Patrick Costello, MS^4*, Sujal I. Shah, MD^7*, Qanber Raze, PhD^8*, Liang S. Lim, PhD^8*, Arnaldo G. Barican^8*, David Howell^8*, David King, PhD^8*, Katherine Towle^4*, Ruben D. Carrasco, MD, PhD^4,7*, Scott J. Rodig, MD, PhD⁷, Jon C. Aster, MD, PhD⁷, Adam S. Sperling, MD, PhD^1,3,4,7, Eric L. Smith, MD, PhD^1,3,4, Jacob Laubach^1,4,7, Nikhil C. Munshi, MD^1,4,7, Kenneth C. Anderson, MD^1,4, Omar Nadeem, MD^1,3,4 and Irene Ghobrial, MD^1,3,4

¹Harvard Medical School, Boston, MA
²Dana-Farber Cancer Institute, Brookline, MA
³Broad Institute of MIT and Harvard, Cambridge, MA
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Centre for Research Training in Genomics Data Science, University of Galway, Galway, Ireland
⁶Apoptosis Research Centre, School of Biological and Chemical Sciences, University of Galway, Galway, Ireland
⁷Brigham & Women's Hospital, Boston, MA
⁸Standard BioTools Canada Inc., Markham, ON, Canada

David Jung, BSc^1*, Holly Lee, MD¹, Sejal Chikhale^1*, Mansour Poorebrahim, PhD^1*, Sungwoo Ahn, PhD^1*, Sacha Benaoudia, PhD^1*, Noemie Leblay, PhD^1*, Francesco Maura, MD², Nizar J. Bahlis, MD¹ and Paola Neri, MD, PhD¹

¹Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
²University of Miami, Coral Gables, FL

Benjamin Diamond, MD¹, Linda B. Baughn, PhD², Mansour Poorebrahim, PhD^3*, Alexandra Maria Poos, PhD^4*, Holly Lee, MD³, Marcella Kaddoura, MD⁵, J Erin Wiedmeier-Nutor, MD, MPH⁶, Michael Durante, MD, PhD^7*, Gregory Otteson^8*, Dragan Jevremovic, M.D., Ph.D^9*, Hongwei Tang, PhD^2*, Stefan Frohling, MD^10*, Marios Papadimitriou, MD^1*, Bachisio Ziccheddu^1*, Tomas Jelinek¹¹, Ola Landgren¹, Paola Neri, MD, PhD³, P. Leif Bergsagel, MD¹², Esteban Braggio, PhD¹³, Shaji Kumar, MD¹⁴, Marc S. Raab^4*, Rafael Fonseca, MD¹⁵, Nizar J. Bahlis, MD³, Niels Weinhold, PhD^4* and Francesco Maura, MD¹

¹Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
²Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
³Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
⁴Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany
⁵Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Dearborn, MI
⁶Division of Hematology, Mayo Clinic, Phoenix, AZ
⁷University of Miami Miller School of Medicine, Miami, FL
⁸Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁹Mayo Clinic, Rochester, MN
¹⁰National Center For Tumor Diseases, Heidelberg, DEU
¹¹Department of Hematooncology, University Hospital Ostrava, Ostrava, Ostrava-Mesto, Czech Republic
¹²Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
¹³Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ
¹⁴Division of Hematology, Mayo Clinic, Rochester, MN
¹⁵Division of Hematology, Mayo Clinic, Paradise Valley, AZ

Umair Munawar^1*, Seungbin Han^2*, Silvia Nerreter^2*, Cornelia Vogt^2*, Shilpa Kurian^2*, Patrick Eiring, PhD^3*, Julia Weingart^3*, Xiang Zhou, MD, BMBS², Markus Sauer, PhD^3*, Hermann Einsele, MD⁴, Leo Rasche, MD^5*, Johannes Waldschmidt, MD² and K. Martin Kortüm, MD^2*

¹University Hospital of Wuerzburg, Wuerzburg, Germany
²Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
³Department of Biotechnology and Biophysics, University of Würzburg, Würzburg, Germany
⁴Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
⁵Department of Internal Medicine II, University Hospital Wurzburg, Wurzburg, Germany

Deeksha Vishwamitra¹, Sheri Skerget, PhD^1*, Diana Cortes-Selva, PhD^2*, Kalpana Bakshi^1*, Lien Vandenberk, PhD^3*, Weili Sun, PhD⁴, Jaszianne Tolbert, MD¹, Colleen Kane, PhD¹, Hein Ludlage, MSc^5*, Bas D Koster, MD, PhD⁶, Julie S Larsen, PharmD^4*, Tobias Kampfenkel, MD, MHBA^7*, Ching Li^1*, Farheen Zishan^8*, Thomas Prior, PhD^1*, Luciano J. Costa, MD, PhD⁹, Jesus G Berdeja, MD¹⁰, Cyrille Touzeau, MD, PhD^11*, Aurore Perrot, MD, PhD¹², Emma Searle, MD, PhD^13*, Jeffrey V Matous, MD¹⁴, Ajai Chari, MD¹⁵, Donna Reece, MD¹⁶, Manisha Bhutani, MD¹⁷, Bhagirathbhai R. Dholaria, MBBS¹⁸, Anita D'Souza, MD, MS^19*, Thomas G. Martin, MD¹⁵, John T. McKay^20*, Alfred L Garfall^21*, Amrita Y Krishnan, MD, FACP²², Niels W.C.J. van de Donk, MD, PhD^23*, Nizar J. Bahlis, MD²⁴ and Ricardo M. Attar, PhD^1*

¹Janssen Research & Development, Spring House, PA
²Johnson & Johnson Innovative Medicine, Spring House, PA
³Janssen Research & Development, Antwerp, Belgium
⁴Janssen Research & Development, Los Angeles, CA
⁵Janssen-Cilag Benelux, Leiden, Netherlands
⁶Janssen Biologics Europe, Leiden, Netherlands
⁷Janssen Research & Development, Neuss, Germany
⁸Janssen Research & Development, High Wycombe, United Kingdom
⁹University of Alabama at Birmingham, Birmingham, AL
¹⁰Tennessee Oncology, Sarah Cannon Research Institute, Nashville, TN
¹¹Centre Hospitalier Universitaire de Nantes, Nantes, France
¹²Centre Hospitalier Universitaire de Toulouse, Oncopole, Toulouse, France
¹³The University of Manchester, Manchester, United Kingdom
¹⁴Sarah Cannon Research Institute, Colorado Blood Cancer Institute, Denver, CO
¹⁵University of California, San Francisco, San Francisco, CA
¹⁶Princess Margaret Cancer Centre, Toronto, ON, Canada
¹⁷Atrium Health Levine Cancer Institute/ Wake Forest School of Medicine, Charlotte, NC
¹⁸Vanderbilt University Medical Center, Nashville, TN
¹⁹Medical College of Wisconsin, Milwaukee, WI
²⁰Wake Forest University School of Medicine, Winston-Salem, NC
²¹Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
²²City of Hope Comprehensive Cancer Center, Duarte, CA
²³Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
²⁴Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada